Peptide Pole Hongkong
Retatrutide
Finnrick tested 4 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Peptide Pole Hongkong between 4 Feb 2026 and 8 Jun 2026. Test scores average below 4 or some scores below 3, and at least 2 tests, warrant a tentative Finnrick Rating of E (Bad).
Finnrick Rating™
Tentative Rating
Peptide Pole Hongkong
Retatrutide
Tested 4 Samples
Last test 8 Jun 2026
Take Action
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Peptide Pole Hongkong
Samples are tested in commercial labs
Tests Count
4
Scores
AVGMINMAX
Last
8 Jun 2026
First
4 Feb 2026
| Quantity | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Batch | Tested | Difference | Purity | Endotoxins | Batch ID | Container | Tested At | Sent By |
| 8 Jun 2026 | View | 10mg | ⚠️ Sample does not contain Retatrutide | n/a | Rt10 | No label / Silver crimp / White cap | Lab G | Public | ||||
| 2 Jun 2026 | View | 10mg | (no batch claim) | 9.19mg | -8.1% | 99.90% | low | March 28th, 2026 | White label / Silver crimp / Blue cap | Lab E | Public | |
| 8 May 2026 | View | 10mg | (no batch claim) | 10.2mg | +2.0% | 99.90% | n/a | Feb 1 2026 | No label / Silver crimp / Green cap | Lab E | Public | |
| 4 Feb 2026 | View | 10mg | 9.8mg | 10.3mg | +5.1% | 99.70% | n/a | PPH-202511 | White Label / Silver Crimp / Green Cap | Lab G | Public | |